AstraZeneca's experimental COVID-19 drug has helped cut the risk of severe disease or death in a late-stage study, the British drugmaker said on Monday,...
AstraZeneca has requested emergency use authorisation from US regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because...
AZD7442 reduced the risk of developing symptomatic COVID-19 by 33% compared to a placebo, which was not statistically significant, the company reported